S. 765 (118th Congress)

Reducing Hereditary Cancer Act of 2023

1/2

Reducing Hereditary Cancer Act of 2023 — Display Title · Nov 13, 2024
A bill to amend title XVIII of the Social Security Act to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation in a blood relative or a personal or ancestral history suspicious for hereditary cancer, and to provide coverage of certain cancer screenings or preventive surgeries that would reduce the risk for individuals with a germline (inherited) mutation associated with a high risk of developing a preventable cancer. — Official Title as Introduced · Nov 13, 2024

Status In Committee

Sponsor Lisa Murkowski

Citation 118-S-765

Actions 2

Introduced Mar 9th, 2023

Cosponsors

Last Action Mar 9th, 2023

Policy Area Health

✓

Introduced Senate Mar 9

Senate

House

President

Enacted

Summary

AI Guide

What this bill does

Loading AI analysis…

Reducing Hereditary Cancer Act of 2023 This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

Actions

Senate

INTRODUCED	INTRODUCED					Mar 9, 2023
ON FLOOR	REFERRED TO COMMITTEE